Integrating the glycemia risk index into clinical practice and research: a consensus report
Umpierrez GE, Shah VN, Brady V, et al.
J Diabetes Sci Technol. Pub. online 7 Mar 2026.
Leggi
An international consensus on screening and monitoring early-stage type 1 diabetes: a roadmap to European implementation
Hussain S, Tree T, Mathieu C, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2026.
Leggi
Enhancing insulin therapy adherence through technology: which needles do people with diabetes prefer?
Gentile S, Fiorentino R, Lettieri M, Guarino G, Marino G, Tommasi E, Frison V, Satta E, Chiarello M, Caccavale G, Masuccio E, Strollo F; on behalf of AMD-OSDI Study Group on Insulin Therapy
Diabetology. Pub. online 9 Mar 2026.
Leggi
Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR
De Cosmo S, Russo G, Nicolucci A, et al.
Clin Kidney J. Pub. online 2 Mar 2026.
Leggi
Impact of continuous glucose monitor on health care resource utilization in adults with type 2 diabetes managed by noninsulin therapies
Sharma AK, Lee A, Mehta S, et al.
Diabetes Technol Ther. Pub. online 1 Mar 2026.
Leggi
Insulin delivery modality and Ramadan fasting interruption, glycemic control, and fear of hypoglycemia in type 1 diabetes: a prospective, multicenter study from Saudi Arabia
Al-Sofiani ME, Alharthi SK, Alsuhaibani M, et al.
Diabetes Res Clin Pract. Pub. online 2 Mar 2026.
Leggi
Gestational diabetes, glycemic management trajectories, and offspring growth patterns and obesity risk
Chehab RF, Greenberg MB, Lee C, et al.
Diabetes Care. Pub. online 4 Mar 2026.
Leggi
Comparative effectiveness of tirzepatide versus dulaglutide or semaglutide on major cardiovascular events in type 2 diabetes and cardiovascular disease: insights from two target-trial emulations
Ostrominski JW, Ortega-Montiel J, Wexler DJ, et al.
Diabetes Care. Pub. online 2 Mar 2026.
Leggi
Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial
Nordanstig J, Arslan EG, Catarig AM, et al.
Eur Heart J. Pub. online 5 Mar 2026.
Leggi
Everyone or just some? cost-effectiveness of general population versus targeted screening strategies for type 1 diabetes in Canada
Mital S, Schatz DA, Haller MJ, et al.
Diabetes Care. Pub. online 2 Mar 2026.
Leggi